Erasca (ERAS) Interest Coverage Ratio (2020 - 2026)
Erasca (ERAS) posted Interest Coverage Ratio of 0.28 for Q1 2026, up 98.72% on a QoQ basis from 21.74 in Q4 2025, and up 98.82% year-over-year from 0.14 in Q1 2025.
Erasca (ERAS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Erasca's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.28 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 98.82% year-over-year to 0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.44 (up 98.42% YoY) and the FY2025 annual result came in at 0.58, up 95.79% from the prior year.
- Interest Coverage Ratio was 0.28 for Q1 2026 at Erasca, up from 21.74 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.28 in Q1 2026 and bottomed at 139.05 in Q4 2022.
- A 5-year average of 14.23 and a median of 2.16 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 99.26% — and 2023, when it tumbled 678.69%.
- Erasca's Interest Coverage Ratio stood at 139.05 in 2022, then jumped by 88.93% to 15.4 in 2023, then tumbled by 36.44% to 21.01 in 2024, then dropped by 3.47% to 21.74 in 2025, then jumped by 98.72% to 0.28 in 2026.
- Business Quant data shows ERAS's Interest Coverage Ratio at 0.28 in Q1 2026, 21.74 in Q4 2025, and 2.09 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Dec 31, 2025 | -21.74 |
| Sep 30, 2025 | -2.09 |
| Jun 30, 2025 | -2.16 |
| Mar 31, 2025 | -23.75 |
| Dec 31, 2024 | -21.01 |
| Sep 30, 2024 | -2.24 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -5.16 |
| Dec 31, 2023 | -15.40 |
| Sep 30, 2023 | -1.34 |
| Jun 30, 2023 | -0.42 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -139.05 |
| Sep 30, 2022 | -0.42 |
| Jun 30, 2022 | -1.17 |
| Mar 31, 2022 | -0.54 |
| Dec 31, 2021 | -104.54 |
| Sep 30, 2021 | -0.19 |
| Jun 30, 2021 | -0.34 |